California Attorney General Rob Bonta, alongside a coalition of eight attorneys general, filed a lawsuit to block the acquisition of Tegna Inc ( TGNA ) by Nexstar Media Group ( NXST ). Tegna and Nexstar are two major broadcast station companies that own and operate television stations throughout the country. "If allowed to proceed, the deal would create the largest broadcast station group in the U...
California Attorney General Rob Bonta, alongside a coalition of eight attorneys general, filed a lawsuit to block the acquisition of Tegna Inc ( TGNA ) by Nexstar Media Group ( NXST ). Tegna and Nexstar are two major broadcast station companies that own and operate television stations throughout the country. "If allowed to proceed, the deal would create the largest broadcast station group in the United States, putting more broadcast programming in the hands of fewer people, removing control from the communities they report to, cutting local jobs, and significantly impacting the delivery of news and other media content to Americans nationwide," the statement said . "Due to the considerable increase in consolidation, the deal is also expected to raise prices and harm consumers." In California, the combined entity would own half of the Big Four (FOX, NBC, ABC, and CBS) network-affiliated stations, including the local FOX and ABC stations in the Sacramento-Stockton-Modesto area and the local FOX and CBS stations in the San Diego area. President Donald Trump last month signaled his support for the deal , saying the transaction would help combat the "Fake News." “Today, my office has filed a lawsuit to block the proposed merger of broadcasting giants Nexstar and Tegna. This merger would cause incredibly high levels of concentration in local TV markets and is expected to raise cable and satellite prices across the country, causing irreparable harm to local news and consumers who rely on their reporting as a critical source of information,” said Attorney General Bonta. Tegna shares fell earlier this month on a report that a coalition of states is preparing to challenge Nexstar Media's ( NXST ) $6.2 billion purchase of the broadcaster. More on TEGNA, Nexstar Media Nexstar Media Group, Inc. (NXST) Presents at Deutsche Bank 34th Annual Media, Internet & Telecom Conference Transcript Nexstar Media Group, Inc. (NXST) Presents at Morgan Stanley Technology, Media & Telecom Confere...
EvgeniyShkolenko/iStock via Getty Images Reasons to Continue Buying CRWV CoreWeave ( CRWV ) traded below $70 when I decided to double down on it three months ago . The stock currently trades above $80, meaning that it was good timing for becoming greedier. On the other hand, CRWV witnessed a notable pullback since late January, but I think it was more sentiment-driven than structural. Investors ar...
EvgeniyShkolenko/iStock via Getty Images Reasons to Continue Buying CRWV CoreWeave ( CRWV ) traded below $70 when I decided to double down on it three months ago . The stock currently trades above $80, meaning that it was good timing for becoming greedier. On the other hand, CRWV witnessed a notable pullback since late January, but I think it was more sentiment-driven than structural. Investors are getting worried about growing leverage and profitability inflection timing, which are legit questions for any business. However, these questions stem from the company's extremely aggressive investments in growth to meet soaring AI infrastructure demand, not because of operating in a dying industry or some strategic missteps. CoreWeave's Investor Relations As of the end of Q4 2025 , the company's backlog amounted to $66.8 billion. It implies a 4x+ increase during 2025, which is absolutely jaw-dropping growth. Out of $66.8 billion, $28 billion (42%) is expected to be recognized within the next 24 months. Considering the fact that CoreWeave's FY2025 revenue amounted to $5.1 billion , the backlog suggests that the company will demonstrate explosive revenue growth over the next few years. The management's revenue forecast for FY2026 is around $12.5 billion, which is the midpoint of the guidance range . It implies a 145% increase compared to FY2025. Given such aggressive revenue growth, the planned increase of capex to $30+ billion looks reasonable because it aligns with the revenue increase. The company's business is capital-intensive because it requires building quite costly and large data centers, and the correlation between backlog/revenue growth looks absolutely fair. Since CRWV is yet to achieve profitability, it is also reasonable that they are raising debt for AI infrastructure buildout. Seeking Alpha Moreover, I believe that the profitability inflection uncertainty is already factored into CRWV's share price. We said that there is a massive revenue backlog, which will ...
Images of mobile devices at the Taiwan Semiconductor Manufacturing Co. (TSMC) Museum of Innovation in Hsinchu, on Tuesday, Jan. 11, 2022. Asian technology stocks fell on Thursday as Iran's latest attacks on Qatar's Ras Laffan Industrial City and a surge in oil prices rattled investor sentiment, amplifying concerns over supply chain disruptions across the semiconductor industry. Materials derived f...
Images of mobile devices at the Taiwan Semiconductor Manufacturing Co. (TSMC) Museum of Innovation in Hsinchu, on Tuesday, Jan. 11, 2022. Asian technology stocks fell on Thursday as Iran's latest attacks on Qatar's Ras Laffan Industrial City and a surge in oil prices rattled investor sentiment, amplifying concerns over supply chain disruptions across the semiconductor industry. Materials derived from Middle Eastern energy markets are used extensively in electronics manufacturing, from printed circuit boards to semiconductor process chemicals. South Korea memory giants SK Hynix and Samsung Electronics fell 2.23% and 1.8% respectively. Seoul Semiconductor shares declined 2.53%. Japan's Advantest fell over 4%, while Tokyo Electron lost 1.99%. Taiwan's TSMC was down 2.1%. China's 'AI tigers' MiniMax and Knowledge Atlas Technology, also known as Zhipu, declined 10% and 8%. The slide comes after a surge in Chinese artificial intelligence stocks following upbeat comments from Nvidia CEO Jensen Huang on the promise of AI agents and OpenClaw. Hong Kong listed stocks of Alibaba slid 3.34%, while Tencent declined 6%. "Recent market moves can almost entirely be attributed to the Middle East conflict and spiking oil prices, macro risks far outweigh company fundamentals for now," said UBP's senior equity advisor Vey-Sern Ling in an email to CNBC. While the immediate concern centers on higher oil prices stoking inflation fears, analysts noted the deeper risk lies in second-order effects rippling through the semiconductor supply chain.
Alvotech press release ( ALVO ): Q4 Revenue of $173M (+13% Y/Y) beats by $13.07M . Adjusted EBITDA was $69 million with Gross Margin at 66% AVT05 was approved as a biosimilar to Simponi in the UK and European Economic Area More on Alvotech Alvotech: Why FDA Delays Don't Break The Bull Case Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag Alvotech higher on p...
Alvotech press release ( ALVO ): Q4 Revenue of $173M (+13% Y/Y) beats by $13.07M . Adjusted EBITDA was $69 million with Gross Margin at 66% AVT05 was approved as a biosimilar to Simponi in the UK and European Economic Area More on Alvotech Alvotech: Why FDA Delays Don't Break The Bull Case Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag Alvotech higher on positive data backing biosimilar to Takeda’s Entyvio Seeking Alpha’s Quant Rating on Alvotech Historical earnings data for Alvotech
Johnson & Johnson (JNJ 0.35%) reached a transition point a few years ago. The company spun off its consumer health business into Kenvue in order to shift its focus and financial resources to its innovative medicine and medtech businesses. J&J did this because these areas showed stronger growth potential moving forward. Meanwhile, J&J's top-selling drug, immunology drug Stelara, lost exclusivity, r...
Johnson & Johnson (JNJ 0.35%) reached a transition point a few years ago. The company spun off its consumer health business into Kenvue in order to shift its focus and financial resources to its innovative medicine and medtech businesses. J&J did this because these areas showed stronger growth potential moving forward. Meanwhile, J&J's top-selling drug, immunology drug Stelara, lost exclusivity, representing a clear headwind for the pharma giant. Since those times, J&J has demonstrated its strength: It's successfully managed the growth of its two main businesses -- even through declines of Stelara. Now, here are two reasons to buy J&J like there's no tomorrow. 1. Strength during times of uncertainty The S&P 500 has slipped this year, amid a variety of concerns, from questions about spending on artificial intelligence (AI) to worries about the war in Iran. Meanwhile, J&J shares have climbed 15%. Pharma stocks generally perform well during times of uncertainty because investors know that risks to their growth are limited -- patients need their medicines and procedures regardless of the economic backdrop. All of this means pharma players are great stocks to own during such environments. And the reason why J&J in particular makes a solid buy now is that the company's portfolio is looking strong. J&J has 28 platforms or products bringing in at least $1 billion annually. In fact, the company recently said it can now place the Stelara loss of exclusivity "in the rearview mirror." Expand NYSE : JNJ Johnson & Johnson Today's Change ( -0.35 %) $ -0.83 Current Price $ 237.28 Key Data Points Market Cap $572B Day's Range $ 235.42 - $ 239.11 52wk Range $ 141.50 - $ 251.71 Volume 6.8M Avg Vol 8.8M Gross Margin 67.97 % Dividend Yield 2.19 % 2. Dividend growth J&J is a Dividend King, meaning it's increased its dividend annually for at least 50 years. This shows a commitment to rewarding shareholders -- so you can buy J&J shares with the idea that your passive income will keep on gro...
Iran and Israel have traded strikes on energy infrastructure in the Middle East, with little sign of the conflict abating. Bloomberg’s Stuart Livingstone-Wallace and Laura Davison join Joumanna Bercetche to discuss the energy market fallout.
Iran and Israel have traded strikes on energy infrastructure in the Middle East, with little sign of the conflict abating. Bloomberg’s Stuart Livingstone-Wallace and Laura Davison join Joumanna Bercetche to discuss the energy market fallout.
Upstage is expanding its partnership with the U.S. chip giant AMD to accelerate next-generation artificial intelligence (AI) model development and advance Korea’s sovereign AI ecosystem. The company announced that the two have agreed to expand their strategic collaboration following a meeting Thursday between its CEO Kim Sung-hoon and AMD Chair and CEO Lisa Su in central Seoul. During the meeting,...
Upstage is expanding its partnership with the U.S. chip giant AMD to accelerate next-generation artificial intelligence (AI) model development and advance Korea’s sovereign AI ecosystem. The company announced that the two have agreed to expand their strategic collaboration following a meeting Thursday between its CEO Kim Sung-hoon and AMD Chair and CEO Lisa Su in central Seoul. During the meeting, the two heads discussed a range of collaboration opportunities to drive AI innovation across the region. As part of this partnership, Upstage will immediately begin deploying AMD’s Instinct MI355 graphics processing unit (GPUs) supported by a multiphase road map over the next year. The company said it plans to use the chips to develop and scale up its large language model, called Solar, and AI-powered document processing engines designed to transform enterprise workflows. "AMD is a cornerstone of global AI computing infrastructure, and this collaboration will be instrumental in both advancing our proprietary Solar LLMs and building Korea's sovereign AI model," Kim said. "Pairing that with domestic infrastructure gives us the foundation to make Korea a genuinely competitive force in global AI." Upstage also intends to use AMD GPUs to support national sovereign AI initiatives, including developing its AI foundation model for the ongoing government-led project. The company is leading one of the four consortia that have advanced to the second round of the project with the Solar Open 100B model. The project will select the final two by the end of this year. Under the expanded collaboration, Upstage and AMD aim to strengthen Korea’s domestic AI ecosystem while diversifying the nation’s sovereign AI infrastructure. “Upstage is at the forefront of AI innovation in Korea, building advanced language models and AI engines that serve enterprises, governments and regulated industries,” the AMD CEO said. “This collaboration brings together AMD Instinct GPUs and the ROCm open software wi...